Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Quality of life in a phase III study of prospective radiation therapy (IMRT) plus /- cetuximab for locally advanced resected head and neck cancer: NRG/RTOG 0920.
Quality of life in a phase III study of prospective radiation therapy (IMRT) plus /- cetuximab for locally advanced resected head and neck cancer: NRG/RTOG 0920. Gwede, C. K., Harris, J., Machtay, M., Le, Q., Thorstad, W., Nguyen-Tan, F., Siu, L. L., Dorth, J., Lee, N. Y., Dunlap, N. E., Chan, J., Bar-Ad, V., Patel, P. R., Chakravarti, A., Rao, S., Shipstone, A., Lanning, R., Attwood, K., Yom, S. S., Movsas, B. LIPPINCOTT WILLIAMS & WILKINS. 2025View details for DOI 10.1200/JCO.2025.43.16_suppl.11123
View details for Web of Science ID 001690360700028